• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: 3S,4R,8R,9S,10S)-10- [(Dimethylamino)methyl]-3,4-dihydroxy-N- (4-methoxyphenyl)-9- [4-(phenylethynyl)phenyl]-1,6-diazabicyclo [6.2.0]decane-6-carboxamide
Date Designated: 06/20/2025
Orphan Designation: treatment of malaria
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Eisai Inc.
200 Metro Blvd.
Nutley, New Jersey 07110
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-